Coinheritance of HNF1A and Glucokinase Variants in Maturity-onset Diabetes of the Young

Overview

Journal Endocrinol Diabetes Metab Case Rep

Specialty Endocrinology

Date 2024 Aug 1

PMID 39089324

Authors

Daisuke Watanabe

Hideaki Yagasaki

Hiromune Narusawa

Takeshi Inukai

Affiliations

Soon will be listed here.

Abstract

Summary: Maturity-onset diabetes of the young (MODY) is a group of monogenic forms of diabetes mellitus characterized by early-onset diabetes with dominant inheritance of beta-cell dysfunction. There are few reports of the coinheritance of glucokinase (GCK) and hepatocyte nuclear factor 1 alpha gene (HNF1A) variants underlying MODY in patients. Herein, we describe a case involving combinations of monoallelic GCK and HNF1A variants associated with MODY. A 10-year-old Japanese girl with a three-generation family history of diabetes without obesity showed high levels of urinary glucose during a school screening test. Her glucose metabolism profile revealed 124 mg/dL of fasting glucose, 6.9% glycated hemoglobin (HbA1c), and 2.78 ng/mL of C-peptide immunoreactivity levels. In a 75-g oral glucose tolerance test, her base glucose, peak glucose, insulin resistance, and homeostasis model assessment of beta cell function levels were 124 mg/dL, 210 mg/dL (120 min), 1.71, and 33%, respectively. Based on the clinical phenotype of GCK-MODY, alimentary and exercise therapy without oral hypoglycemic agents were used to maintain her fasting glucose and HbA1c levels. We explored the coinheritance of MODY with GCK and HNF1A variants in this and past cases and found that careful clinical follow-up is required to firmly establish phenotypic features. Moreover, the accumulation of data on genetically confirmed MODY associated with the coinheritance of GCK and HNF1A variants will be useful for understanding genotype-phenotype correlations.

Learning Points: MODY is a group of monogenic forms of diabetes mellitus characterized by early-onset diabetes with the dominant inheritance of beta-cell dysfunction. MODY2 and MODY3 caused by heterozygous loss-of-function variants in the glucokinase (GCK) and hepatocyte nuclear factor 1 alpha (HNF1A) genes, respectively, are the most common forms of the disease. Few cases of MODY have previously been reported as being associated with the coinheritance of GCK and HNF1A variants. Careful clinical follow-up is required to firmly establish phenotypic features in the coinheritance of MODY with GCK and HNF1A variants. The accumulation of data on genetically confirmed MODY associated with the coinheritance of GCK and HNF1A variants will be useful for understanding genotype-phenotype correlations.

References

Lopez-Garrido M, Herranz-Antolin S, Alija-Merillas M, Giralt P, Escribano J . Co-inheritance of HNF1a and GCK mutations in a family with maturity-onset diabetes of the young (MODY): implications for genetic testing. Clin Endocrinol (Oxf). 2012; 79(3):342-7. DOI: 10.1111/cen.12050. View

Lucchesi D, Randazzo E, Del Prato S, Bianchi C . An Italian MODY family with proband and son carrying variants in GCK and HFN1A: is it a true case of digenic MODY?. Acta Diabetol. 2023; 61(1):131-134. DOI: 10.1007/s00592-023-02171-3. View

Behl R, Malhotra N, Joshi V, Poojary S, Middha S, Gupta S . Meta-analysis of HNF1A-MODY3 variants among human population. J Diabetes Metab Disord. 2022; 21(1):1037-1046. PMC: 9167412. DOI: 10.1007/s40200-022-00975-8. View

Feng L, Wang Y, Qin J, Fu Y, Guo Z, Zhang J . UGT1A Gene Family Members Serve as Potential Targets and Prognostic Biomarkers for Pancreatic Cancer. Biomed Res Int. 2021; 2021:6673125. PMC: 8478536. DOI: 10.1155/2021/6673125. View

Wright C, Smith C, Jiggins C . Alternative splicing as a source of phenotypic diversity. Nat Rev Genet. 2022; 23(11):697-710. DOI: 10.1038/s41576-022-00514-4. View

Pearson E, Velho G, Clark P, Stride A, Shepherd M, Frayling T . beta-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1alpha and glucokinase mutations. Diabetes. 2001; 50 Suppl 1:S101-7. DOI: 10.2337/diabetes.50.2007.s101. View

Bennett J, Vasta V, Zhang M, Narayanan J, Gerrits P, Hahn S . Molecular genetic testing of patients with monogenic diabetes and hyperinsulinism. Mol Genet Metab. 2015; 114(3):451-8. PMC: 7852340. DOI: 10.1016/j.ymgme.2014.12.304. View

Kim S, Ma X, Klupa T, Powers C, Pezzolesi M, Warram J . Genetic modifiers of the age at diagnosis of diabetes (MODY3) in carriers of hepatocyte nuclear factor-1alpha mutations map to chromosomes 5p15, 9q22, and 14q24. Diabetes. 2003; 52(8):2182-6. DOI: 10.2337/diabetes.52.8.2182. View

Kraja A, Chasman D, North K, Reiner A, Yanek L, Kilpelainen T . Pleiotropic genes for metabolic syndrome and inflammation. Mol Genet Metab. 2014; 112(4):317-38. PMC: 4122618. DOI: 10.1016/j.ymgme.2014.04.007. View

10.

FAJANS S, Bell G, Polonsky K . Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med. 2001; 345(13):971-80. DOI: 10.1056/NEJMra002168. View

11.

Massa O, Meschi F, Caumo A, Cerutti F, Toni S, Cherubini V . High prevalence of glucokinase mutations in Italian children with MODY. Influence on glucose tolerance, first-phase insulin response, insulin sensitivity and BMI. Diabetologia. 2001; 44(7):898-905. DOI: 10.1007/s001250100530. View

12.

Pozo F, Rodriguez J, Vazquez J, Tress M . Clinical variant interpretation and biologically relevant reference transcripts. NPJ Genom Med. 2022; 7(1):59. PMC: 9579139. DOI: 10.1038/s41525-022-00329-6. View

13.

Martin-Morales L, Rofes P, Diaz-Rubio E, Llovet P, Lorca V, Bando I . Novel genetic mutations detected by multigene panel are associated with hereditary colorectal cancer predisposition. PLoS One. 2018; 13(9):e0203885. PMC: 6157886. DOI: 10.1371/journal.pone.0203885. View

14.

Glotov O, Serebryakova E, Turkunova M, Efimova O, Glotov A, Barbitoff Y . Whole‑exome sequencing in Russian children with non‑type 1 diabetes mellitus reveals a wide spectrum of genetic variants in MODY‑related and unrelated genes. Mol Med Rep. 2019; 20(6):4905-4914. PMC: 6854535. DOI: 10.3892/mmr.2019.10751. View

15.

Suzuki K, Akiyama M, Ishigaki K, Kanai M, Hosoe J, Shojima N . Identification of 28 new susceptibility loci for type 2 diabetes in the Japanese population. Nat Genet. 2019; 51(3):379-386. DOI: 10.1038/s41588-018-0332-4. View

16.

Vits L, Beckers D, Craen M, De Beaufort C, Vanfleteren E, Dahan K . Identification of novel and recurrent glucokinase mutations in Belgian and Luxembourg maturity onset diabetes of the young patients. Clin Genet. 2006; 70(4):355-9. DOI: 10.1111/j.1399-0004.2006.00686.x. View

17.

Iafusco F, Maione G, Mazzaccara C, Candia F, Mozzillo E, Franzese A . NGS Analysis Revealed Digenic Heterozygous and Variants in a Child with Mild Hyperglycemia: A Case Report. Diagnostics (Basel). 2021; 11(7). PMC: 8306687. DOI: 10.3390/diagnostics11071164. View

18.

Lee D, Kwak S, Park H, Ku E, Jeon H, Oh T . Identification of candidate gene variants of monogenic diabetes using targeted panel sequencing in early onset diabetes patients. BMJ Open Diabetes Res Care. 2021; 9(1). PMC: 8211067. DOI: 10.1136/bmjdrc-2021-002217. View